M&A Deal Summary |
|
|---|---|
| Date | 2002-06-17 |
| Target | CroMedica International |
| Sector | Healthcare Services |
| Buyer(s) | PRA Health Sciences |
| Deal Type | Add-on Acquisition |
| Advisor(s) | Edgemont Capital Partners LP (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1976 |
| Sector | Life Science |
| Employees | 17,500 |
| Revenue | 3.1B USD (2019) |
PRA Health Sciences, Inc. is an international clinical research organization. PRA provides services on a contract basis to the pharmaceutical and biotechnology industries. Comprehensive services include the filing of Investigational New Drug (IND) and similar regulatory applications, management and implementation of Phase I through IV clinical trials, preparation and submission of New Drug Applications (NDAs), and post-marketing surveillance on an international basis. PRA was formed in 1976 and is based in Raleigh, North Carolina.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 8 |
| Sector (Healthcare Services) | 1 of 2 |
| Type (Add-on Acquisition) | 1 of 8 |
| State (British Columbia) | 1 of 1 |
| Country (Canada) | 1 of 1 |
| Year (2002) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-06-19 |
Pharma Bio-Research BV
Zuidlaren, Netherlands PBR is a market leader in the management of complex Phase I and Phase IIa clinical trials of new drugs on behalf of the world's top pharmaceutical and biotechnology firms. |
Buy | €85M |
